Circumstances of discovery

Frequency (%)

P-value

Voluntary screening

98/379 (5.86%)

PMTCT

56/379 (14.78%)

<2.2e−16

Diagnosis/Clinical suspicion

196/379 (51.71%)

Not specified

29/379 (7.65%)

WHO clinical stage

Stage I (asymptomatic)

128/379 (33.77%)

Stage II (moderate)

49/379 (12.93%)

<2.2e−16

Stage III (advanced)

195/379 (51.45%)

Stage IV (severe)

28/379 (7.39%)

Body Mass Index (BMI) (Kg/m²)

<18.5

60/303 (19.8%)

18.5 ≤ BMI 0 < 25

153/303 (50.5%)

<2.2e−16

25 ≤ BMI 0 < 30

48/303 (15.84%)

≥30

42/303 (13.86%)